HLS Therapeutics Inc.
(MENAFN- Baystreet) 10:50 AM EST - HLS Therapeutics Inc.: Announces that it has entered into an agreement with Bayer Inc. to commercialize VERQUVO® (vericiguat) in Canada. HLS Therapeutics Inc.
shares T are trading up $0.03 at $4.50.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Comments
No comment